Table 3. Linear regression models of the boost in eosinophil number at 9 weeks post-treatment.
Full model | Reduced model | |
β (SE) | β (SE) | |
Sex | 0.113 (0.079) | - |
Village-group | 0.132 (0.085) | - |
Age (v. 5–6 yrs) 7–9 | 0.027 (0123) | - |
10–14 | −0.016 (0.133) | - |
15–23 | −0.035 (0.146) | - |
24–34 | 0.010 (0.132) | - |
35–40 | −0.170 (0.152) | - |
log infection intensity | 0.054 (0.022)* | 0.061 (0.020)** |
log pre-treatment SWA-IgE | 0.007 (0.029) | - |
log 24 hr eotaxin | −0.056 (0.045) | - |
log 24 hr IL-5 | 0.115 (0.032)*** | 0.121 (0.028)*** |
p<0.05,
p<0.01,
p<0.001.